Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus
Open Access
Abstract
Systemic lupus erythematosus (SLE) is a chronic inflammatory disease with various clinical features. Autoreactive B cells play a role in disease pathogenesis, through the production of multiple autoantibodies, which form immune complexes and induce the inflammatory response and tissue damage associated with SLE. Recently, tetraspanins, and in particular, TSPAN32, have been recognized to play a central role in immunity, as they are involved in various biological processes, such as the antigen presentation and the activation of lymphocytes. Evidence suggests that tetraspanins could represent in the future a target for therapeutic purposes in patients suffering from autoimmune/immunoinflammatory disorders. In the present study, by performing in silico analyses of high-throughput data, we evaluated the expression levels of TSPAN32 in B cell activation and investigated its modulation in circulating B cells from SLE patients. Our data show that B cell activation is associated with a significant downregulation of TSPAN32. Additionally, significantly lower levels of TSPAN32 were observed in circulating plasmablasts from SLE patients as compared to healthy donor plasmablasts. In addition, type I interferons (IFNs)-related genes were enriched among the genes negatively correlated to TSPAN32, in SLE plasmablasts. Accordingly, IFN-α is able to induce a dose-dependent downregulation of TSPAN32 in B cells. Overall, the data here presented suggest the potential use of TSPAN32 as a diagnostic marker and therapeutic target for the evaluation and management of humoral immune responses in chronic diseases, such as SLE.Keywords
Funding Information
- Università di Catania (“Piano di incentivi per la ricerca di Ateneo” 2020/2022 (Pia.ce.ri.))
This publication has 32 references indexed in Scilit:
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseasesNature, 2014
- Asthmatics with exacerbation during acute respiratory illness exhibit unique transcriptional signatures within the nasal mucosaGenome Medicine, 2014
- Systemic Lupus ErythematosusNew England Journal of Medicine, 2011
- Single Round of Antigen Receptor Signaling Programs Naive B Cells to Receive T Cell HelpImmunity, 2010
- HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2010
- Initiation of Antigen Receptor-Dependent Differentiation into Plasma Cells by Calmodulin Inhibition of E2AThe Journal of Immunology, 2009
- The tetraspanin web modulates immune-signalling complexesNature Reviews Immunology, 2005
- The Absence of Tssc6, a Member of the Tetraspanin Superfamily, Does Not Affect Lymphoid Development but Enhances In Vitro T-Cell Proliferative ResponsesMolecular and Cellular Biology, 2002
- Phemx, a Novel Mouse Gene Expressed in Hematopoietic Cells Maps to the Imprinted Cluster on Distal Chromosome 7Genomics, 2000
- In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activityLupus, 1996